On 11th Aug., 2012, a great news spreads from Shijiazhuang Rainbowlabs Pharmaceutical Technology Co., Ltd: Rainbowlabs has received the official approval letter from U.S. Food and Drug Administration (hereinafter referred to as FDA) which confirms RainbowlabsÃ¢â‚¬â„¢ testing ability. The letter states clearly that Rainbowlabs has achieved FDAÃ¢â‚¬â„¢s approval, and indicates that Rainbowlabs has become one of a handful of testing laboratory enterprises confirmed by FDA throughout the country and the only high-tech laboratory enterprise in North China with FDA approval.
FDA is one of the most authoritative and strictest global drug quality control organization. Having achieved FDA approval means that the quality system and testing ability of Rainbowlabs have reached the highest international standards. Shijiazhuang Rainbowlabs Pharmaceutical Technology Co., Ltd approved by FDA pushes firmly domestic pharmaceutical enterprises to be admitted into European and American regulation markets, to overcome trade barriers, and to enter into international high-end medical market. Meanwhile, it sets up a new quality benchmarking for Chinese pharmaceutical industry who takes part in the R&D of new products and technologies according to the highest international quality standards.
Shijiazhuang Rainbowlabs Pharmaceutical Technology Co., Ltd will continue to increase the effort of international registration and certification, insist constantly in the combination strategy between quality innovation and high-end access, push the front quality standard and comprehensive management level of Shijiazhuang as a medical town of China, and make more contribution for capital economy development and human health career.